Single Ascending Dose Study of TRN-157 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

TRN-157

DRUG

Placebo

Trial Locations (1)

Unknown

Cypress

All Listed Sponsors
lead

Theron Pharmaceuticals, Inc.

INDUSTRY

NCT02133339 - Single Ascending Dose Study of TRN-157 in Healthy Subjects | Biotech Hunter | Biotech Hunter